Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Diabetes Drug Shakeup: What You Need to Know About New FDA Warnings
Motley Fool
Tue, 04/19/16 - 09:50 am
Tags:
FDA, diabetes, AstraZeneca, Takeda, Nesina, Onglyza, Eli Lilly, JNJ, Trajenta, Jardiance, Invokana
Eli Lilly And Boehringer Reveals Study On Jardiance For Treatment Heart Failure
Yahoo/Benzinga
Tue, 04/19/16 - 09:47 am
Tags:
Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes, chronic heart failure
3 Big Battles Brewing in Biotech
Motley Fool
Sun, 04/10/16 - 01:50 pm
Tags:
AstraZeneca, ZS-9, Relypsa, Veltassa, Synergy Pharmaceuticals, plecanatide, Linzess, Ironwood, Allergan, Incyte, Eli Lilly, baricitinib, AbbVie, Humira
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
Fierce Biotech
Fri, 04/8/16 - 10:59 am
Tags:
AstraZeneca, Eli Lilly, BACE inhibitors, Alzheimer's disease, AZD3293
$35M deal: Incyte licenses Lilly drug for potential new use
Bizjournals.com
Wed, 04/6/16 - 10:20 pm
Tags:
Incyte, Eli Lilly, ruxolitinib, graft vs host disease
Insulin prices have skyrocketed, putting drug makers on the defensive
Stat
Wed, 04/6/16 - 09:56 am
Tags:
insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk, Medicare
Study shows no clinical benefit from Lilly cholesterol drug
BioPharma Dive
Mon, 04/4/16 - 09:50 am
Tags:
Eli Lilly, evacetrapib, CTEP inhibitors
New cholesterol methods needed in wake of failed drugs, heart researchers say
Yahoo/Reuters
Sun, 04/3/16 - 10:53 am
Tags:
cholesterol, Eli Lilly, Pfizer, Roche
Lilly's new arthritis drug beats placebo in latest successful trial
Fierce Biotech
Thu, 03/31/16 - 08:18 pm
Tags:
Eli Lilly, clinical trials, baricitinib, rheumatoid arthritis
FDA approves Eli Lilly drug for psoriasis
Yahoo/Reuters
Wed, 03/23/16 - 09:43 am
Tags:
FDA, Eli Lilly, psoriasis, ixekizumab
Will Eli Lilly's 11th-hour regulatory gambit salvage or sink its Alzheimer's drug?
Fierce Biotech
Tue, 03/22/16 - 10:02 am
Tags:
Eli Lilly, Alzheimer's disease, solanezumab
Lilly Alzheimer's Study Change Piles Risk on Top of Risk
TheStreet.com
Tue, 03/15/16 - 10:18 pm
Tags:
Eli Lilly, Alzheimer's disease, solanezumab, clinical trials
Novo Nordisk Follows Eli Lilly as Worthy Rival to Merck in Diabetes
Bidness, ETC
Tue, 03/8/16 - 10:14 am
Tags:
Novo Nordisk, Eli Lilly, Merck, diabetes, Victoza
Eli Lilly Aiming To Restart Growth With Pipeline Of Hot Drugs
Investors.com
Wed, 03/2/16 - 11:06 am
Tags:
Eli Lilly
Drugmakers partner in immuno-oncology, to better capture market share
Medical Marketing and Media
Wed, 03/2/16 - 11:00 am
Tags:
Opdivo, immuno-oncology, Bristol-Myers Squibb, Eli Lilly, Merck, Roche, AstraZeneca, Novartis
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
BioPharma Dive
Fri, 02/26/16 - 09:34 am
Tags:
Eli Lilly, Portrazza, Europe, biologics, non-small cell lung cancer
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
BioPharma Dive
Wed, 02/24/16 - 04:48 pm
Tags:
romosozumab, Amgen, osteoporosis, clinical trials, Eli Lilly, Forteo, Radius Health, abaloparatide
7 big pharma companies sign on to Parkinson's development group
BioPharma Dive
Wed, 02/24/16 - 11:49 am
Tags:
R&D, AbbVie, AstraZeneca, Biogen, Eli Lilly, Merck, Pfizer, UCB Pharma, Parkinson's Disease
Eli Lilly and Co.’s 4Q15 Changes in Growth Rate
Yahoo/Market Realist
Sun, 02/14/16 - 11:04 am
Tags:
Eli Lilly
Eli Lilly Just Lost the Latest Round in its Patent Battle
Fortune
Fri, 02/12/16 - 10:01 am
Tags:
Eli Lilly, patents, Alimta, lung cancer, UK, Allergan, generics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.